Background Sacubitril-valsartan reduces the risk of cardiovascular mortality among patients with heart failure with reduced ejection fraction (HFrEF). However, its long-term protective effects on cardiac function with concurrent acute kidney injury (AKI)
Hyo Jeong Kim +5 more
semanticscholar +1 more source
Induction of ischaemic cardiomyopathy in mice without off‐target effects
Experimental Physiology, EarlyView.
Mark T. Waddingham, James T. Pearson
wiley +1 more source
Effects of LCZ696 (Sacubitril/Valsartan) on Blood Pressure in Patients with Hypertension: A Meta-Analysis of Randomized Controlled Trials [PDF]
Qiang Geng +3 more
openalex +1 more source
PCV100 Real-World IMPACT of Sacubitril/Valsartan on the Quality of Life of Heart Failure Patients in Portugal [PDF]
Marta Afonso Nogueira +9 more
openalex +1 more source
The effect of angiotensin receptor neprilysin inhibitor, sacubitril/valsartan, on central nervous system amyloid-β concentrations and clearance in the cynomolgus monkey [PDF]
Bateman, Randy J, et al,
core +2 more sources
ObjectiveTo detect muscular system adverse reaction signals of sacubitril/valsartan treatment combined with statins (atorvastatin, rosuvastatin, simvastatin) to provide a reference for clinical administration.MethodsMultiplicative and additive models ...
Fukun Zhao +4 more
doaj +1 more source
138 Matching the Uptake of Sacubitril/Valsartan to Heart Failure Prevalence in Australia [PDF]
M. Kalsi, N. Dayawansa, V. Mutha
openalex +1 more source
PROTECTIVE EFFECTS OF ULTRASOUND-BASED PREOPERATIVE EXOGENOUS SACUBITRIL/VALSARTAN ON THE HEART AND KIDNEY OF PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION [PDF]
YUNFEI WANG
openalex +1 more source

